SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-24-213687
Filing Date
2024-09-05
Accepted
2024-09-05 07:32:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d880385dsctota.htm SC TO-T/A 28666
2 EX-99.(A)(5)(D) d880385dex99a5d.htm EX-99.(A)(5)(D) 13642
3 GRAPHIC g880385g0905025000084.jpg GRAPHIC 1804
4 GRAPHIC g880385g0905025000339.jpg GRAPHIC 1543
  Complete submission text file 0001193125-24-213687.txt   49018
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90214 | Film No.: 241279956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ROERVANGSVEJ 30 HOLBAEK G7 DK-4300
Business Address ROERVANGSVEJ 30 HOLBAEK G7 DK-4300 45 5948 5959
Pharmacosmos A/S (Filed by) CIK: 0002032940 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)